NewBiologix

#NewBiologix CEO & Co-Founder Igor Fisch and Chief Operating Officer Déborah Ley are headed to Biotechnology Innovation Organization-Europe in Stockholm, Sweden, from November 4–6, 2024! NewBiologix is committed to helping partners advance the treatment of rare, chronic, and incurable diseases by closing the innovation gap in economically viable, large-scale viral vector production for gene therapy. Let's connect and explore how we can drive this mission forward together—reach out to request a meeting! #BIOEurope #Innovation #GeneTherapy

According to data presented at the 2024 Cell & Gene Meeting on the Mesa, the cell and gene therapy industry is beginning to recover from recent investment challenges, with $10.9 billion raised in the first half of this year. While smaller, preclinical-stage companies have faced difficulties securing funding, there is renewed optimism for the future. With increasing investments in cell and gene therapy, we are excited about the opportunity to help our partners develop life-changing innovations and offer hope for improved quality of life to patients. Read more 👉 https://bit.ly/3UtH2Ur

#NewBiologix is on the ground at the European Society of Gene and Cell Therapy Annual Meeting in Rome! We've had a productive week engaging in lively discussions, cutting-edge research presentations, and collaborative exchanges with top scientific leaders in #GeneTherapy. Please reach out to Efrain Guzman, Luca Nanni, or Pelin Kolçak Yaşlı, Ph.D., to continue discussions about how NewBiologix can help you revolutionize the field of gene therapy! #ESGCT2024

We are excited to announce that two of our abstracts have been selected for poster presentations at the 31st Annual European Society of Gene and Cell Therapy Congress (ESGCT)! Our presentations will highlight our innovative #CellLine technologies designed to overcome the traditional limitations of #GeneTherapy production. Presentation Details: Generation and Characterization of a HEK293 Cell Line for rAAV production October 22 | 19:30 - 21:00 CEST | P0039 An Integrated Platform for the Analysis and Quality Control of rAAV Vectors Based on Long-read Sequencing October 23 | 13:30 - 15:00 CEST | P0174 Join us in Rome to explore how we’re advancing the future of gene therapy! #NewBiologix #ESGCT2024

Press Release: NewBiologix has been selected for two poster presentations at the 31st Annual European Society for Gene & Cell Therapy Congress (ESGCT), taking place October 22-25, 2024, at La Nuvola in Rome, Italy. Pelin Kolçak Yaşlı, Ph.D. to present Oct. 22 at 19:30 and Luca Nanni on Oct. 23 at 13:30. Learn More about the presentations here >> https://bit.ly/3UddSsx

Gene and cell therapies are poised to shape the next decade of biomedical innovation. By enabling gene replacement, we’re moving beyond disease treatment towards potential cures. At NewBiologix, we’re proud to support this transformative future with our advanced sequencing and bioinformatics solutions and our NBX-Eng-HEK293 cell line for transient rAAV production, ensuring accurate cell line analysis and rAAV production for the next frontier of gene therapy discovery. Don't miss the latest episode of BioWorld Insider, where Astellas Pharma CCO Claus Zieler explores the impact of gene and cell therapies on the future of innovation: https://bit.ly/3BX2PNO

Introducing our proprietary, high-performance, engineered HEK293 cell line for reliable and efficient rAAV pre-clinical and commercial production. NBX-Eng-HEK293 is a HEK293 suspension host cell line that has been precision-engineered for high rAAV productivity while maintaining phenotypic and genomic stability. With a comprehensive genetic makeup package, NBX-Eng-HEK293 is the ideal choice for in-house transient transfection processes and scalable production. Learn more: https://lnkd.in/ef7bU-zq #NewBiologix #rAAV #GeneTherapy #Biotechnology

Déborah Ley will be attending Cell & Gene on the Mesa Oct 7 - 9 in Phoenix. Request a meeting or connect with her at one of the receptions to learn more about the latest innovations in gene therapy vector production. #CGMesa24 #NewBiologix #bioinformatics #genetherapy #AAV

🔬 At NewBiologix, we specialize in delivering tailored sequencing and bioinformatics solutions focused on comprehensive cell line analysis. Our services include the analysis of modification and characterization of cell lines through advanced genomic, epigenetic, and transcriptomic techniques, ensuring precise and insightful data to support a wide range of scientific inquiries. Innovating the future of genomics, one solution at a time >> https://bit.ly/3z1H2ni #Genomics #Bioinformatics #NextGenSequencing #ResearchInnovation #NewBiologix

✨ We enjoyed our time at Ilmac in Lausanne! ✨ It was a pleasure sharing our latest innovations at NewBiologix through Luca Nanni's insightful presentation. We’re excited to continue the conversations sparked at ILMAC! Dario Bottinelli, Déborah Ley, #ILMAC2024 #Innovation #GeneTherapy #AAV #NBX #Lausanne #Biotech